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A central paradox in the cell biology of the 
  immune system revolves around understanding 
how the same receptor for antigen can either 
signal immunogenically to stimulate prolifera-
tion and diff  erentiation in response to foreign 
antigens, or signal tolerogenically to inactivate or 
eliminate cells that bind to self-antigens. A clear 
example of this paradox is the phenomenon of 
clonal anergy in B lymphocytes. Anergy is an 
active process of immunological self-  tolerance 
brought about by exposure to self-antigens by 
which self-reactive lymphocytes adopt a state 
where they are refractory to making an immune 
response to antigen. Instead, anergic B cells 
make tolerance-promoting responses to antigen, 
such as exclusion from lymphoid follicles, apop-
tosis, or active inhibition of plasma cell diff  eren-
tiation. Corresponding biochemical changes in 
B cell receptor (BCR) signaling in anergic cells 
have been identifi  ed by analyzing hen egg lyso-
zyme (HEL)-specifi  c B cells that have become 
anergic to HEL by maturing in animals express-
ing HEL systemically and comparing them with 
developmentally matched B cells bearing the 
same receptor that are naive. In anergic cells, 
BCR signaling in response to antigen is uncou-
pled from NF-κB and c-Jun N-terminal kinase 
(JNK) but continues to activate extracellular 
  signal–regulated kinase (ERK) and calcium oscil-
lations that drive NFAT nuclear shuttling (1, 2). 
These changes in signaling have major tran-
scriptional and functional consequences (3). The 
lack of NF-κB activation prevents induction of 
NF-κB target genes, such as c-myc, IRF4, 
bcl-XL, and A1 that are normally required for 
B cell proliferative responses to antigen. The 
continued activation of NFAT is likely to induce 
CD5 and CD72, which have inhibitory roles, and 
the chronic activation of ERK inhibits plasma 
cell diff  erentiation (4). Similar changes in BCR 
signaling have been documented in anergic 
B cells from several transgenic models (5, 6).
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Divergent hypotheses exist to explain how signaling by the B cell receptor (BCR) is initi-
ated after antigen binding and how it is qualitatively altered in anergic B cells to selec-
tively uncouple from nuclear factor 𝗋B and c-Jun N-terminal kinase pathways while 
continuing to activate extracellular signal–regulated kinase and calcium–nuclear factor of 
activated T cell pathways. Here we fi  nd that BCRs on anergic cells are endocytosed at a 
very enhanced rate upon binding antigen, resulting in a large steady-state pool of intracel-
lularly sequestered receptors that appear to be continuously cycling between surface and 
intracellular compartments. This endocytic mechanism is exquisitely sensitive to the lower-
ing of plasma membrane cholesterol by methyl-𝗃-cyclodextrin, and, when blocked in this 
way, the sequestered BCRs return to the cell surface and RelA nuclear accumulation is 
stimulated. In contrast, when plasma membrane cholesterol is lowered and GM1 sphingo-
lipid markers of membrane rafts are depleted in naive B cells, this does not diminish BCR 
signaling to calcium or RelA. These results provide a possible explanation for the signaling 
changes in clonal anergy and indicate that a chief function of membrane cholesterol in 
B cells is not to initiate BCR signaling, but instead to terminate a subset of signals by rapid 
receptor internalization.
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A key question is how BCR signaling is qualitatively al-
tered in anergic B cells. In naive but not anergic cells, antigen 
causes IgM and IgD BCRs to partition into a biochemical 
cell fraction that is relatively resistant to detergent extraction 
and associated with the cytoskeleton. This occurs before 
BCR phosphorylation and is unaff   ected by inhibition of 
BCR phosphorylation and src kinase activity (7). These re-
sults lead to the hypothesis that anergy stems from changes in 
the subcellular partitioning or traffi   cking of BCRs. An alter-
native hypothesis is favored by work in cell lines showing 
that Igα and Igβ dissociate from membrane IgM and IgD af-
ter antigen stimulation and BCR desensitization (8). More-
over, when chimeric BCRs that do not associate with Igα 
and Igβ are coexpressed with normal BCRs, a minority of 
these unsheathed BCRs interfere with signaling to antigen in 
a way that resembles anergy (9).
Resolving how BCR signaling is altered in anergic B cells 
is made more diffi     cult because of fundamental questions 
about the basic mechanism of BCR signal transduction. The 
BCR is formed by a 1:1 protein complex composed of a 
membrane-bound Ig molecule and a noncovalently associ-
ated Igα-Igβ heterodimer (10). The membrane-bound Ig is 
responsible for the recognition and binding to the antigen, 
whereas the Igα and Igβ molecules are responsible for signal-
ing to SH2-bearing tyrosine kinases through their immuno-
receptor tyrosine-based activation motifs (ITAMs). Several 
models currently exist to explain how binding of antigen ini-
tiates intracellular signal cascades in B cells. In one model, 
antigen binding causes receptor clustering that in some way 
favors partitioning of the receptor into cholesterol/sphingo-
lipid-rich membrane microdomains and/or coalescence of 
these domains. Microdomains are hypothesized to form plat-
forms concentrating important signaling molecules, such as 
lyn, BTK, and PLCγ2, and excluding inhibitory signaling 
molecules, such as CD45, to produce an optimal environ-
ment around the receptor for initiating signaling (11–13). 
  Alternatively, clustering of antigen receptors may promote 
tyrosine kinase activation by transphosphorylation indepen-
dently of the membrane microenvironment (14). Finally, 
a very diff  erent model for initiating BCR signaling (10) pro-
poses that BCR clustering or perturbation by antigen acti-
vates syk kinase by BCR-produced H202 and local oxidative 
inhibition of tyrosine phosphatases (15). In the latter models, 
association of BCRs with cholesterol-rich microdomains 
plays no role in signal initiation but might favor interactions 
with microdomain-associated Lyn kinase to terminate signal-
ing, consistent with Lyn’s critical in vivo role as a BCR signal 
inhibitor (16, 17). Thus, there are widely divergent views 
on the mechanism of BCR signal initiation and the role of 
membrane microdomains.
To understand how the BCR is selectively uncoupled 
from NF-κB in anergic cells, in this study we have compared 
the fate of cell surface receptors in naive and anergic B cells 
and the eff  ects of depleting membrane cholesterol. We iden-
tify a striking alteration in BCR subcellular partitioning, 
  involving a dramatically enhanced shuttling and temporary 
sequestration of BCRs intracellularly. Paradoxically, given 
the view that cholesterol-rich microdomains promote BCR 
signaling, we fi   nd that decreasing membrane cholesterol 
does not disrupt immunogenic signaling to calcium or 
NF-κB in naive B cells, but completely inhibits and reverses 
BCR sequestration in anergic cells resulting in reactivation 
of signals to NF-κB. These results indicate that membrane 
cholesterol serves a chief, rate-limiting role to inhibit signal-
ing by BCRs, at least in part through promoting a process of 
receptor endocytosis and recycling that is remarkably en-
hanced in anergic cells.
RESULTS
Monomeric HEL does not induce capping of surface IgD 
despite being a potent inducer of RelA nuclear 
accumulation in naive B lymphocytes
Previous data demonstrated that anergic B cells have a simi-
lar amount of surface IgD to naive controls (18) and that 
there is no detectable diff  erence between IgM and IgD in 
their capacity to activate naive HEL-specifi  c cells (19). In 
addition, our previous biochemical data from fractionated 
cell extracts indicated diff  erences in IgM and IgD association 
with membrane/cytoskeletal fractions in anergic cells (7). We 
used confocal microscopy to investigate the possibility that 
uncoupling from NF-κB was associated with diff  erences in 
subcellular distribution of the BCR on the cell membrane. 
IgD localization and activation of the NF-κB pathway were 
followed in the same cells using confocal microscopy after 
staining permeabilized cells with antibodies to IgD and the 
NF-κB   subunit RelA.
On naive B cells (BCR Tg cells), IgD staining with or 
without permeabilization of the membrane with Triton 
X-100 was comparable, indicating that most of the IgD is on 
the cell surface and diff  usely distributed before stimulation 
(Fig. 1, B and D). Stimulation with monomeric HEL did 
not induce any appreciable patching or capping of the sur-
face IgD but nevertheless effi   ciently induced accumulation 
of RelA in the nucleus of the naive B cells (Fig. 1, A and F, 
and Figs. S2 and S3, which are available at http://www.jem.
org/cgi/content/full/jem.20060552/DC1). These results 
indicate that microscopically visible patching or capping of 
receptors is not required for effi   cient signaling. Interestingly, 
parallel studies using stimulation of the BCR on naive B 
cells with a nonmitogenic preparation of goat anti-κ light 
chain antibody induced very large caps of IgD but without 
appreciable accumulation of RelA in the nucleus (Fig. 1, A, 
C, and E). Collectively, these data emphasize the weak cor-
relation between BCR capping and immunogenic signaling 
to the NF-κB signaling pathway and indicate that if raft-
coalescing mechanisms are involved in this signaling, they 
must occur at a submicron scale not readily resolvable by the 
light microscope.
Anergic B cells have an intracellular sequestered pool of IgD
In opposition to naive B cells, the staining pattern of 
IgD in permeabilized versus nonpermeabilized anergic cells JEM VOL. 203, July 10, 2006  1775
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(BCR tg x sHEL tg cells) revealed striking diff  erences. In non-
permeabilized cells, cell surface IgD was distributed homoge-
neously around the plasma membrane (Fig. 1 B, no TX100). 
Once permeabilized, however, anergic cells uniquely exhib-
ited a large pool of IgD polarized at one pole of the cell, ap-
parently under the plasma membrane in the confocal plane of 
observation (Fig. 1, B and D, and Figs. S2 and S3). To con-
fi  rm this observation, the cells were stained fi  rst with anti–
IgDa-FITC to reveal and saturate cell surface receptors, and 
the cells were then fi  xed, permeabilized, and restained with 
IgDa-Cy3 to reveal intracellular IgD. The results confi  rmed 
the existence of a large intracellular pool of IgD in anergic 
cells (Fig. 2 A and Fig. S4, which is available at http://www.
jem.org/cgi/content/full/jem.20060552/DC1). In addition, 
cells were incubated with HEL-biotin at 4°C, fi  xed, saponin 
permeabilized, and stained with SAV-PE and an anti-HEL 
mAb coupled to cychrome (Fig. S5, available at http://www.
jem.org/cgi/content/full/jem.20060552/DC1). FACS plots 
are shown in Fig. 2 B and demonstrate the presence of a large 
pool of antigen inside anergic cells correlating with the exis-
tence of an intracellular pool of IgD in these cells. As previ-
ously described using biochemical methods, HEL stimulation 
did not stimulate nuclear accumulation of RelA in anergic B 
cells (Fig. 1, A, E, and F, and Fig. S3) (2).
Figure 1.  Anergic B cells fail to accumulate RelA in the nucleus 
but contain a large pool of intracellular IgD. (A) Immunofl  uorescent 
staining and confocal observations were performed on Triton X-100–
permeabilized naive B cells (BCR tg) or anergic B cells (BCR tg x sHEL tg). 
Staining for IgDa and RelA was analyzed after HEL stimulation (HEL 
30 min), goat anti-κ light chain stimulation (Anti-Kappa 30 min), or 
without stimulation (Unstim.). Note that the thin rim of cytoplasmic and 
plasma membrane staining for IgD readily demarcates the nucleus of 
these small lymphocytes. (B) IgD staining was performed on Triton 
X-100–permeabilized or on nonpermeabilized (no TX100) cells to com-
pare the distribution of surface receptors only with the distribution of 
intracellular plus surface IgD receptors. (C) 300–900 permeabilized cells 
were observed per condition per experiment, and cells displaying a po-
larized accumulation of IgDa at one pole in the focal plane were counted. 
Mean + SD values are obtained from three to six independent experi-
ments. (D) As in C, except that cells were either not permeabilized 
(no TX100) or permeabilized (TX100) before staining for IgD. (E and F) As 
C and D, cells displaying predominantly nuclear localization of RelA in 
the midline focal plane of the cells, as shown in A, were counted. Open 
bars, BCR tg; fi  lled bars, BCR tg x sHEL tg. Stimulation time is 30 min for 
C, D, and E and as indicated in F.1776  CHOLESTEROL IN BCR SIGNALING AND ANERGY | Bléry et al.
Membrane cholesterol extraction does not interfere 
with BCR signaling to antigen in naive cells
The next experiments were designed to investigate whether 
or not cholesterol-rich microdomains were involved in the 
diff  erences in NF-κB signaling by BCRs on naive and aner-
gic cells. The small cyclic oligosaccharide methyl-β-cyclo-
dextrin (MBCD) binds cholesterol reversibly, allowing 
cholesterol to be depleted from or added to cell membranes 
(20). To measure the lowering of plasma membrane choles-
terol by MBCD, cells were stained for FACS with the anti-
biotic fi  lipin, which binds to cholesterol and has fl  uorescent 
properties (21). Filipin staining decreased  50% upon MBCD 
treatment (Fig. 3, B and C). Treatment with cholesterol-
loaded MBCD did not signifi  cantly change the level of fi  lipin 
staining from mock-treated controls (Fig. 3, B and C) and 
was therefore used as an additional control to exclude possi-
ble nonspecifi  c eff  ects of MBCD. Cholesterol depletion by 
MBCD was reversible by subsequent treatment with MBCD 
loaded with cholesterol (not depicted). In addition to lower-
ing plasma membrane cholesterol, MBCD treatment also 
Figure 2.  Polarized intracellular accumulation of IgD and antigen 
in anergic B cells. (A) Representative confocal images of naive or aner-
gic B cells. Cells were stimulated as indicated, placed on ice, stained with 
saturating doses of an anti–IgDa-FITC mAb (IgDa-FITC, surface), and then 
fi  xed, permeabilized, and stained with an anti-IgDa mAb-biotin and SAV-
Cy3 (IgDa-Cy3, permeabilized) to reveal intracellular IgD. (B) FACS staining 
on unstimulated naive or anergic cells, either nonpermeabilized (bold 
lines) or saponin permeabilized (shaded histograms). Surface BCRs avail-
able to bind HEL were measured by staining with HEL-biotin before sapo-
nin treatment, followed by streptavidin-PE, whereas all BCR-bound HEL 
antigen was stained with anti–HEL cychrome antibody. Note that the 
anti-HEL cychrome staining of anergic cells is twice as high on permeabi-
lized cells compared with nonpermeabilized cells, demonstrating that half 
of the HEL-engaged BCRs are located intracellularly. There is no difference 
in surface IgD staining between the naive and anergic cells, and the lower 
staining for HEL-biotin on the latter refl  ects occupancy of half of the 
surface BCRs with untagged HEL and down-regulation of surface IgM.
Figure 3.  Effects of depleting cholesterol from membranes of 
  naive and anergic B cells. (A) Surface levels of raft-associated GM1 
sphingolipids and IgDa were measured by fl  ow cytometry before (gray 
histogram) and after treatment with the indicated concentrations of 
MBCD (open histograms). The dotted lines serve as an arbitrary visual 
reference for control fl  uorescence levels. (B) Membrane cholesterol levels 
were measured by staining with fi  lipin and fl  ow cytometric measurement 
of fi  lipin fl  uorescence on untreated cells (Control), MBCD-treated cells 
(MBCD), or cells treated with MBCD that had been preloaded with choles-
terol (MBCD-Chol). (C) Values of the mean fl  uorescence of the fi  lipin 
staining were normalized with the value obtained for untreated and 
  unstimulated BCR tg cells. Open bars, BCR tg cells; fi  lled bars, BCR tg x HEL tg 
cells. Data shown are representative of two to fi  ve independent experi-
ments. (D) HEL antigen-induced calcium responses were recorded as 
  variations in the Indo-1 fl  uorescence ratio gated on the B220+ cell 
  population. Bold lines, calcium response of control cells; thin lines, cells 
that were fi  rst pretreated with 2.5 mM MBCD. Stimulation is performed 
after 60 s with soluble HEL. Experiment shown is representative of fi  ve 
independent experiments.JEM VOL. 203, July 10, 2006  1777
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dramatically reduced the amount of cell surface GM1 glyco-
sphingolipids, as measured by staining with fl  uorescent chol-
era toxin B subunit (Fig. 3 A). This result is consistent with 
disruption of lipid rafts by cholesterol lowering with MBCD. 
Despite the clear eff  ects of MBCD on the plasma membrane 
composition of naive B cells, this procedure had no eff  ect on 
the expression of surface IgD (Fig. 3 A) and, surprisingly, did 
not interfere with antigen-induced calcium responses (Fig. 3 D) 
or RelA nuclear translocation (Fig. 4, A and B).
Cholesterol depletion redistributes sequestered IgD 
to the cell surface and restores RelA nuclear 
accumulation in anergic cells
The eff  ects of MBCD treatment were studied in parallel in 
anergic B cells. There were no diff  erences in fi  lipin staining 
between untreated naive and anergic B cells, indicating that 
the levels of free cholesterol in the membrane are comparable 
(Fig. 3, B and C). Likewise, there was no diff  erence between 
anergic and naive B cells in plasma membrane GM1 glyco-
sphingolipids stained with cholera toxin (Fig. 3 A). MBCD 
treatment diminished fi  lipin and cholera toxin staining to a 
comparable amount on anergic B cells and had no eff  ect on 
antigen-  induced calcium responses (Fig. 3, A, C, and D). 
However, in contrast to naive B cells, when anergic B cells 
were treated with MBCD there was a striking eff  ect on cell 
surface IgD expression, with the median amount of surface IgD 
increasing  50% (Fig. 3 A). In parallel, confocal microscopy 
showed that the intracellular pool of IgD was diminished (Fig. 
4 C). Thus, the intracellular pool of sequestered IgD in anergic 
cells is maintained by a cholesterol-dependent mechanism and 
is redistributed to the cell surface when cholesterol is lowered.
Surprisingly, MBCD treatment of anergic cells also in-
duced accumulation of RelA in the nucleus (Fig. 4, A and B). 
This eff  ect appeared spontaneous in that it did not require 
HEL antigen to be added to the anergic cells in vitro and was 
not augmented by adding antigen to the cells in vitro. How-
ever, the RelA translocation is likely to be antigen dependent 
because more than half of the antigen receptors on anergic 
cells are already occupied with HEL antigen in vivo, and no 
RelA translocation was stimulated by MBCD in naive cells 
lacking HEL on their receptors. Thus, the lowering of mem-
brane cholesterol by MBCD in anergic cells appears to rees-
tablish BCR signaling to NF-κB.
Accelerated BCR endocytosis in anergic B cells and its 
disruption by plasma membrane cholesterol extraction
The data described above demonstrated that the intracellular 
pool of sequestered IgD in anergic cells required membrane 
Figure 4.  MBCD treatment restores RelA nuclear accumulation 
in anergic B lymphocytes. (A) Staining for IgDa and RelA and confo-
cal analysis were performed on permeabilized B cells. The cells were 
fi  rst treated with MBCD or left untreated, and then either stimulated 
with HEL for 30 min or left unstimulated, as indicated. (B) Quantitation 
of cells with nuclear RelA accumulation. Open bars, naive BCR tg cells; 
fi  lled bars, anergic BCR tg x HEL tg cells. Mean + SD is calculated 
from three independent experiments, where 300–900 cells were 
counted each time. (C) As in B, but cells with polarized IgDa staining 
were counted.1778  CHOLESTEROL IN BCR SIGNALING AND ANERGY | Bléry et al.
cholesterol to be maintained (Fig. 3 A), but this gave no in-
formation about the dynamics of this pool and whether cho-
lesterol was required to promote IgD removal from the cell 
surface or prevent recycling back to the cell surface. A fl  ow 
cytometric method was developed to measure the rate of en-
docytosis of antigen receptors. Cells were incubated on ice 
with HEL antigen coupled covalently to PE (HEL-PE), and 
then the cells were placed at 37 or 4°C for varying periods of 
time. Endocytosis can only occur at 37°C and was stopped at 
diff  erent times by placing the cells on ice. The cells were then 
exposed to a brief acid wash, which rapidly inactivates the 
fl  uorescence of phycoerythrin remaining on the cell surface. 
Endocytosed HEL-PE is protected from acid exposure inside 
the cell and remains brightly fl  uorescent, allowing sensitive 
measurement of the proportion of initially bound antigen 
that has been internalized (Fig. 5 A). Endocytosis of the anti-
gen occurred rapidly within the fi  rst minute at 37°C in aner-
gic B cells, and most of the bound fl  uorescent antigen is 
protected within 10 min (Fig. 5 B). In contrast, endocytosis 
in naive cells had a slower onset, and the fraction of bound 
fl  uorescent antigen that was protected was half that achieved 
in anergic cells (Fig. 5 B). Quantifying the rate of endocytosis 
over the fi  rst 10 min using the method of Liu et al. (22) dem-
onstrated an approximate doubling in anergic cells compared 
with their naive counterparts (Fig. 5 B, right).
Depletion of plasma membrane cholesterol with MBCD 
dramatically inhibited the rate and overall amount of antigen 
endocytosis in both anergic and naive B cells (Fig. 5 B). 
  Endocytosis of antigen was also inhibited by a specifi  c inhibi-
tor of Src kinase activity, PP1, and by an actin polymerisation 
inhibitor, latrunculin B (Fig. 5 C). Endocytosis of antigen 
was inhibited by the protein kinase C (PKC) inhibitor 
  rottlerin. Rottlerin is specifi  c for PKC-δ at low concentration 
(3–6 μM), inhibits PKC-β and PKC-γ at medium concen-
tration (30–42 μM), and inhibits PKC-ε, PKC-η, and PKC-ζ 
at high concentration (80–100 μM) (23). Endocytosis of the 
antigen was 50% inhibited by 5 μM rottlerin (Fig. 5 C). This 
result suggests that endocytosis is dependent on PKC-δ, al-
though this conclusion must be qualifi  ed by the broad poten-
tial specifi  city of this compound. Collectively, these results 
indicate that a rapid, active, cholesterol-dependent process of 
BCR endocytosis is dramatically enhanced in anergic cells 
compared with naive cells. When endocytosis is stopped by 
MBCD treatment, the receptors recycle and accumulate back 
on the cell surface.
The rapid rate of internalization is consistent with clathrin-
mediated BCR internalization, which has been shown to be 
the major pathway for BCR endocytosis and depends upon 
membrane cholesterol and clathrin phosphorylation by lyn 
kinase (24, 25). Clathrin-mediated endocytosis is blocked by 
depleting cellular potassium or by the presence of sucrose in 
the extracellular fl  uid. In four independent experiments, su-
crose decreased HEL-PE endocytosis to 4 ± 3% (mean ± 
SD) of control levels in naive cells and to 7 ± 8% in anergic 
cells. Potassium depletion decreased internalization to 37 ± 
31% and 40 ± 28% of control levels in naive and anergic 
cells, respectively. There were no signifi  cant diff  erences be-
tween naive and anergic cells in the relative inhibition by ei-
ther agent, indicating that the accelerated rate of endocytosis 
in anergic cells occurs by the same clathrin-mediated path-
way that occurs in naive B cells.
Figure 5.  Enhanced BCR endocytosis in anergic cells. (A) Histo-
grams showing HEL-PE fl  uorescence of B220+ naive (BCR) or anergic 
(BCR tg x sHEL tg) cells. Cells were either acid treated to inactivate the 
fl  uorescence of cell surface PE so remaining signal measures endocytosed 
antigen (shaded histograms), whereas control cells (open histograms) 
provide a measure of total surface and intracellular HEL-PE. Cells kept at 
4°C serve as a no endocytosis control, whereas cells warmed to 37°C for 
10 min before acid treatment reveal the fraction of bound antigen that 
has been internalized. (B) Time course of antigen endocytosis. ●, anergic 
B cells; ○, naive B cells. Dashed lines show endocytosis by cells with cho-
lesterol lowered by 2.5 mM MBCD, and solid lines are corresponding val-
ues for mock-treated controls. The experiment shown is representative of 
three independent experiments. The right panel shows the rate of endocy-
tosis for the fi  rst 10 min calculated from the dashed line on the left panel. 
Values represent the mean of three independent experiments. (C) Pharma-
cological inhibition of antigen endocytosis in naive cells (open columns) 
and anergic cells (fi  lled columns). The amount of antigen endocytosed by 
untreated cells after 10 min was set to 100%. The effect of each treat-
ment is expressed as relative endocytosis compared with the untreated 
value (Untd.). PP1, rottlerin (Rottl.), and latrunculin B (Lat B) were used at 
the indicated concentrations. Data shown are representative of two to 
fi  ve independent experiments.JEM VOL. 203, July 10, 2006  1779
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To distinguish if the endocytosed antigen receptors on 
anergic cells normally recycle back to the cell surface or only 
after MBCD lowering of cholesterol, we developed a FACS 
assay to measure receptor recycling (Fig. 6). HEL antigen was 
labeled with biotin coupled via a thiol-cleavable linker. After 
occupying surface BCRs with HEL-SS-biotin and allowing 
endocytosis at 37°C for 10 min, antigen remaining on the sur-
face was cleaved from its biotin tag by exposure to MESNA, 
a membrane-impermeant reducing agent. Thus, intracellularly 
sequestered antigen would selectively retain biotin label.   After 
cleavage, we cultured the cells at 37°C for varying times to 
allow internalized antigen to return to the cell surface, where 
it was detected by staining with streptavidin coupled to al-
lophycocyanin. Using this assay, 14 ± 5% (mean ± SD) of 
internalized antigen could be shown to return to the cell sur-
face of anergic cells within 3 min, and 10 ± 5% was recycled 
at the same time in naive cells (Fig. 6, A and B). The frac-
tion of endocytosed receptors recycled back to the surface 
is likely to be an underestimate because of the rapid rate of 
internalization (Fig. 5). The higher percentage of initially 
  antigen-labeled receptors coming back to the surface in aner-
gic cells suggested a more rapid shuttling of BCRs between 
the surface and the intracellular compartment (Fig. 6 B).
DISCUSSION
The data described above provide an unexpected insight into 
the role of membrane cholesterol in BCR signaling and the 
mechanisms for altering signaling in anergic B cells. We fi  nd 
that antigen-engaged BCRs on anergic cells are endocytosed 
at twice the rate of naive cells, resulting in a large steady-state 
pool of intracellularly sequestered receptors and antigen that 
appear to be rapidly exchanging between surface and intra-
cellular compartments (Figs. 1, 2, 5, and 6). This endocytic 
mechanism is exquisitely sensitive to cholesterol lowering by 
MBCD. When endocytosis is blocked, the intracellular BCRs 
with antigen bound to them accumulate on the plasma mem-
brane to increase the surface IgD density on anergic cells (Fig. 
3) and RelA nuclear accumulation is stimulated when pre-
viously it was blocked. Moreover, when plasma membrane 
cholesterol is lowered and GM1 sphingolipid markers of 
membrane rafts are greatly reduced in naive B cells, this does 
not diminish BCR signaling to calcium or RelA.
It is surprising that MBCD treatment of naive cells, de-
spite markedly lowering membrane cholesterol and GM1, 
does not interfere with initiation of BCR signals for calcium 
or for RelA translocation. In the simplest terms, this result 
does not support the hypothesis that initiation of BCR sig-
naling depends on translocation to cholesterol and GM1-rich 
lipid rafts (13). Membrane cholesterol can only be lowered 
by  50% to still maintain good B cell viability; however, it 
could reasonably be argued that the cholesterol-dependent 
rafts needed to initiate signaling are either diffi   cult to extract 
or tolerate a moderate reduction in cholesterol and GM1 
content. The data are nevertheless more consistent with the 
alternative hypotheses that BCR signaling is initiated by cho-
lesterol-independent mechanisms for altering the balance 
  between syk and tyrosine phosphatase activity (14, 15). Also 
favoring this view are other fi  ndings that BCR signaling is 
initiated outside lipid rafts in the immature B cell line WEHI-
231 (26) and the observation in the Ramos cell line that dis-
rupting microdomains by cholesterol lowering with MBCD 
does not interfere with BCR signaling to calcium but instead 
enhances it (27). Taken together with our results in anergic 
cells, this suggests that the critical, rate-limiting function of 
Figure 6.  Rapid recycling of antigen-loaded BCRs to the cell 
  surface. (A) Naive or anergic B cells were incubated with HEL-SS-biotin 
at 4°C, warmed to 37°C for 10 min to allow endocytosis, and then the 
remaining surface antigen was cleaved of biotin with MESNA. The cells 
were then warmed again to 37°C for the indicated times and stained 
with streptavidin-APC to detect material returning to the cell surface. The 
experiment shown is representative of three independent experiments. 
(B) Percentage of reexpressed receptor bound to antigen in three 
 independent  experiments.1780  CHOLESTEROL IN BCR SIGNALING AND ANERGY | Bléry et al.
MBCD-sensitive cholesterol in the membrane is to inhibit 
BCR signaling to RelA by promoting endocytosis.
These data do not exclude a separate role for coalescence 
of lipid rafts or attachment to the plasma membrane cytoskel-
eton so that they remain on the cell surface, for example as 
part of the process of sustaining immunogenic BCR signaling 
by Btk (28) or enhancing signaling through CD21/CD19 
(29, 30). Formation of an endocytosis-resistant cytoskeletally 
attached microdomain as an early step in immunogenic 
  signaling would be consistent with the observation that 
BCRs on naive but not anergic cells associate with detergent-
resistant domains attached to the cytoskeleton, before and 
  independently of src kinase activation (7). These microdomains 
may be organized simply by cytoskeletal specializations and 
not necessarily involve cholesterol-rich membrane domains. 
Formation of a putative B cell synapse by coalescence of lipid 
rafts has been proposed to be important to form stable com-
plexes that would eventually be capped and internalized (13). 
Microscopically visible structures that could correspond to an 
immunogenic B cell synapse have been documented between 
HEL-specifi   c splenic B cells and antigen-presenting cells 
  displaying membrane-bound HEL (31). The signifi  cance 
  attributed to visible, micron-sized rearrangements must be 
tempered, however, by functional data showing that the 
  optimal number of receptors that need to be stably collected 
into a single cluster on the cell surface for an immunogenic 
B cell response—a so-called immunon—is in the order of 
16–20, which represents a structure in the nanometer scale 
(32, 33). Similarly, HEL antigen signals effi   ciently to NF-κB 
without forming microscopically visible patches or caps, 
whereas extensive capping of BCRs and co-capping of GM1 
with an anti-κ antiserum is not accompanied by eff  ective 
NF-κB signaling (Fig. 1).
Accelerated cycles of IgD endocytosis and reexpression 
may account for the uncoupling of signals to NF-κB and 
JNK as well as for the continued signaling to ERK and 
chronic oscillatory stimulation of calcium that collectively 
distinguish anergic B cells from naive cells. ERK activation and 
low calcium oscillations in anergic cells are not constitutive 
events but require continued reexposure to HEL antigen (1). 
It is notable that calcium elevation and ERK activation occur 
within seconds of antigen binding to naive B cells, whereas 
NF-κB and JNK activation take several minutes. We fi  nd 
that endocytosis begins within 1 min in anergic cells (Fig. 5). 
A member of the membrane-associated guanylate kinase fam-
ily of proteins, Carma1 (also called Card-11), is critical for 
BCR signaling to NF-κB and JNK but not required for cal-
cium, NFAT, or ERK activation (34). Carma1 has numerous 
protein–protein interaction sites and, by analogy with mem-
brane-associated guanylate kinase proteins at the postsynaptic 
densities of neurons, is required to assemble an elaborate 
  signaling complex (an “immunosome”) at the plasma mem-
brane comprising surface receptors and signaling molecules 
for NF-κB and JNK activation (34–37). The accelerated 
  endocytosis of BCRs in anergic cells may frustrate assembly 
of the Carma1 immunosome needed for NF-κB and JNK 
signaling, and may withdraw the BCR from the plasma 
membrane pool of PIP2 needed as a substrate for PLCγ, thus 
limiting intracellular calcium to low oscillations. The sus-
tained BCR signaling to ERK in anergic cells is consistent 
with recent data from receptor tyrosine kinases and the 
  adrenergic receptor showing that signaling to ERK via src 
kinases continues after receptor sequestration to recycling 
  endosomes (38). The correlation between inhibition of endo-
cytosis and induction of RelA nuclear accumulation when 
cholesterol is lowered in anergic cells nevertheless does not 
establish a direct linkage between these two eff  ects. It is con-
ceivable that a cholesterol-dependent process other than 
  endocytosis is responsible for preventing RelA nuclear accu-
mulation in anergic cells.
Several independent lines of evidence support the con-
clusion that accelerated BCR endocytosis in anergic cells 
contributes to their diminished proliferative response. Stoddart 
et al. (24, 25) have shown that rapid BCR internalization at 
the rate observed here depends upon clathrin heavy chain 
and its phosphorylation by tyrosine kinases in cholesterol-
  dependent membrane domains. When clathrin-mediated en-
docytosis is blocked in DT40 cells, BCR induced tyrosine 
phosphorylation and ERK activation is prolonged. The ac-
celerated internalization of BCRs on anergic cells resembles 
that observed in splenic B cells from Igβc->αc gene-targeted 
mice engineered to bear two copies of the Igα cytoplasmic 
tail in the BCR instead of a heterodimer of Igα and Igβ tails 
(39). B cells in Igβc->αc mice are also anergic, displaying di-
minished calcium and proliferative responses to BCR en-
gagement. Comparison with and crosses to mice with mutated 
Igα ITAM tyrosines demonstrated that the diminished sur-
face IgD density and anergy of Igβc->αc B cells is partly cor-
rected by halving the number of functional ITAMs per BCR 
(39). Collectively, these results indicate that B cell anergy in-
volves augmentation of an inhibitory process of clathrin/cho-
lesterol-dependent endocytosis that depends upon src family 
kinases, BCR ITAM phosphorylation, and unique residues 
in the Igα cytoplasmic tail.
The observation that BCR endocytosis in anergic and 
naive cells is inhibited by rottlerin at low concentration sug-
gests that PKC-δ is required (Fig. 5). This observation is in-
teresting in light of data from Mecklenbrauker et al. (40) who 
showed that PKC-δ was necessary for B cell anergy and pre-
venting RelA nuclear accumulation in the same model ana-
lyzed here. PKC-δ may thus favor tolerogenic signaling, in 
part by promoting endocytosis of the anergic receptor or its 
localization to MBCD-sensitive domains.
Collectively, our data reveal an acceleration of BCR en-
docytosis and a surprising relationship between membrane 
cholesterol, BCR endocytosis, and RelA nuclear accumula-
tion that may explain the qualitative changes in BCR signal-
ing in B cell clonal anergy. It will be important in future 
work to explore how this mechanism is enhanced in anergy 
and how it may be regulated in other situations where anti-
gen receptor signals are qualitatively altered, such as B cell 
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MATERIALS AND METHODS
Mice. Mice transgenic for the MD4 anti-HEL–specifi  c BCR were bred 
  either to B6 mice (BCR tg) or to mice expressing the soluble HEL ML5 
transgene (BCR tg x HEL tg) (41). All mice used were between 11 and 22 wk 
of age. All experiments involving animals were performed under protocols 
approved by the Animal Ethics & Experimentation Committee of The 
  Australian National University.
Antibodies and drugs. Biotinylated anti-CD43, biotinylated anti-Ter119, 
and anti–Igβ-FITC were purchased from BD Biosciences, and rabbit anti-
RelA was from Santa Cruz Biotechnology, Inc. The anti-IgDa AMS9.1-
  biotin and the B220-FITC were produced and purifi  ed in our laboratory. 
HEL conjugated to PE (HEL-PE) was prepared by reductive cross-linking 
of R-PE with HEL. In brief, 11 μl of 10 mg/ml SMCC (succinimidyl 
4-(N-maleimidomethyl)cyclohexane-1-carboxylate; Pierce Chemical Co.) 
in DMSO per mg of R-PE in 50 mM sodium phosphate, pH 7.01, 1 mM 
EDTA was incubated for 60 min at room temperature to yield a maleimide-
labeled PE. HEL was reduced in 50 mM MES buff  er with 20 mM DTT. 
Excess reagents were removed, and buff  er pH was changed by passing both 
preparations on D-salt excellulose desalting column (Pierce Chemical Co.) 
to have both preparations in 50 mM MES, pH 6.0, 2 mM EDTA. Coupling 
consisted of reacting maleimide groups on the PE with free sulfhydryl groups 
on the HEL molecules. 3.2 mg PE per mg of HEL was incubated at room 
temperature for 50 min and 34 μg N-ethyl maleimide at 100 mg/ml in 
DMSO was added per mg of HEL for 20 min at room temperature to stop 
the reaction. Conjugated HEL-PE was fi  nally dialyzed in PBS. Streptavidin 
(SAV)-Cy3 and donkey anti–rabbit IgG-Cy5 or FITC were obtained from 
Jackson ImmunoResearch Laboratories. MBCD, fi  lipin, nystatin, sucrose, 
HEL, and latrunculin B were obtained from Sigma-Aldrich. Rottlerin was 
from Pierce Chemical Co. and was provided by N. Ozsarac (John Curtin 
School of Medical Research [JCSMR], Canberra City, Australia). HEL-
dextran was provided by C. Garcia de Vinuesa (JCSMR). Indo-1-AM was 
purchased from Invitrogen and used at 1 μM according to the manufactur-
er’s instructions. Calcium analysis was acquired on an LSR fl  ow cytometer 
(Becton Dickinson) and analyzed with FlowJo (Tree Star Inc.).
B cell purifi  cation and stimulation. Splenocytes from mice were sub-
jected to a negative selection using biotinylated anti-CD43 and anti-Ter119 
antibodies with magnetic MACS beads coupled to streptavidin (Miltenyi 
Biotec) in DMEM without phenol red 2% FCS, 10 mM Hepes, 0.1 mM 
nonessential amino acids, 1 mM sodium pyruvate, and 55 μM 2-ME and 
supplemented with penicillin and streptomycin (referred hereafter as “me-
dium”) as described previously (7). 90–98% B220+ cell purity was routinely 
achieved. Pretreatment of the cells at 2 × 107 cells per ml with drugs was 
performed in microcentrifuge tubes in medium for 30 min at 37°C as indi-
cated in the fi  gures. For fi  lipin, nystatin, and hypertonic sucrose treatment, 
there was no serum in the medium. Concentrated soluble HEL was then 
added to a fi  nal concentration of 10 μg/ml for the time indicated. A dose re-
sponse to MBCD established that concentrations higher than 5 mM caused 
B cell death, but those at 2.5–5 mM caused little cell death. Untreated cells 
were also preincubated for 30 min at 37°C before stimulation. 2.5 mM 
MBCD loaded with cholesterol was prepared as described by Christian et al. 
(20). Potassium depletion treatment was performed by incubating the cells 
for 5 min at 37°C in a 1:1 mix of medium and distilled water. Cells were then 
put in water containing 100 mM NaCl and 50 mM Hepes for 20 min before 
stimulation. The cells were kept in that buff  er for all subsequent steps.
Confocal microscopy. After stimulation, ice-cold PBS was used to wash 
the cells and cells were allowed to rest on 0.1% poly-l-lysine–coated cover-
slips for 5 min before a 2-min spin at 94 g. Fixation was performed for 10 min 
at 4°C followed by 10 min at room temperature with 2% paraformaldehyde 
(PFA) in PBS. Quenching of the PFA was done for 15 min with 0.1% 
NaBH4 in PBS, and cells were permeabilized (if indicated) with 0.1% Triton 
X-100 in PBS for 4 min. Blocking was performed for 30 min in PBS con-
taining 0.1% gelatin, 5% BSA, 2% serum from the species of the secondary 
antibody used, 0.1% azide, and 1 μg/ml Fc block (anti-CD16/32 from BD 
Biosciences). All of these steps were performed at room temperature. Anti-
bodies were incubated from 1 h at room temperature to overnight at 4°C in 
PBS containing 0.1% BSA and 0.1% azide, coverslips were washed, and fl  uo-
rescent secondary antibodies were incubated for 1 h at room temperature. 
Several washes in PBS and in water were performed before mounting cover-
slips onto slides with fl   uorescent mounting medium (DakoCytomation). 
Observations were performed with a Radiance 2000 confocal microscope 
using Laser Sharp software (Bio-Rad Laboratories). Sequential acquisitions 
of each channel were performed to avoid compensation problems. Single 
color controls and secondary antibody controls were used to set up the 
  detectors. A z-stack of confocal sections was collected, and sections through 
the midline of the cell nucleus were used for analysis as illustrated in Fig. S1, 
which is available at http://www.jem.org/cgi/content/full/jem.20060552/
DC1. Images were processed and analyzed using Graphic Converter and 
Adobe Photoshop software.
Endocytosis assay. 4 × 106 splenocytes at 2 × 107 cells per ml were incu-
bated in DMEM medium as described above, with 10 μg/ml HEL-PE in 
microcentrifuge tubes on ice for 30 min. Cells were washed once with me-
dium and resuspended in medium at 2 × 107 cells per ml, and the suspension 
was split in equal proportions in two new tubes and incubated at 4 or 37°C 
for the time indicated. Each cell suspension was again split between two new 
tubes on ice. One tube was centrifuged at 500 g, and the cells were resus-
pended at 2 × 107 cells per ml in PBS 0.1% BSA, 0.1% azide for FACS 
staining and held on ice (untreated samples). In the second tube, cells were 
centrifuged at 500 g and resuspended in 0.5 ml of 150 mM NaCl, 150 mM 
acetic acid, pH 2.7, and left on ice for 3 min before the addition of 0.5 ml 
FCS (FCS was added directly to the tube to stop the acid treatment). After 
centrifugation and removal of supernatant, this treatment was repeated once 
and cells were resuspended in PBS 0.1% BSA 0.1% azide for FACS staining 
on ice (acid-treated samples).
All samples were counterstained with B220-FITC and analyzed by gat-
ing on B220+ cells and measuring the (geometric) mean PE fl  uorescence of 
the population. Because endocytosis does not occur at 4°C, the level of PE 
fl  uorescence at 4°C with acid treatment was defi  ned as the minimal fl  uores-
cence (Fmin). Maximal fl  uorescence (Fmax) was defi  ned as the PE fl  uores-
cence at 4°C without acid treatment, which represents the starting amount 
of HEL-PE bound to the cells without endocytosis. Means of PE fl  uores-
cence obtained at 37°C with acid treatment provide the measure (F) of en-
docytosed PE in each condition or time point. To calculate the percent of 
initially bound HEL-PE that was endocytosed at each condition or time 
point, the formula (F-Fmin)/(Fmax-Fmin)×100 was used.
Recycling assay. HEL-SS-biotin was prepared from sulfo-NHS-SS-biotin 
(catalog no. 21331; Pierce Chemical Co.) according to the manufacturer’s 
instructions. In brief, 1 ml HEL at 10 mg/ml in PBS was incubated with 166 μl 
sulfo-NHS-SS-biotin at 50 mM in PBS for 2 h on ice (molar excess of biotin 
to protein is 12). Reaction product was dialyzed in PBS to remove unre-
acted sulfo-NHS-SS biotin. Purifi  ed B cells were incubated with 10 μg/ml 
HEL-SS-biotin in medium for 30 min on ice. Cells were washed once with 
medium and incubated at 37°C for 10 min for endocytosis to occur. Endo-
cytosis was then stopped by washing the cells with ice-cold medium, and 
surface biotin was cleaved by a 60-min treatment with medium without 
  serum containing 50 mM 2-mercaptoethanesulfonic acid (MESNA; Sigma-
Aldrich) on ice (22). Cells were washed with ice-cold medium and incu-
bated for the indicated time at 37°C to allow reexpression of the receptors to 
the surface. Cells were washed in ice-cold PBS 0.1% azide and fi  xed in PBS 
2% PFA for 20 min on ice. Finally, cells were stained with B220-FITC and 
SAV-PE in PBS 0.1% BSA 0.1% azide before FACS acquisition. Percentage 
of reexpressed receptor bound to antigen was calculated using the for-
mula  (F-Fmin)/(Fmax-Fmin)×100. F is the fl   uorescence obtained with 
SAV-APC for each condition. Fmin is the minimal fl  uorescence obtained 
for samples incubated for 10 min at 37°C, treated with MESNA for 1 h at 
4°C, and not put back at 37°C for reexpression (MESNA, 0 min, 37°C). 1782  CHOLESTEROL IN BCR SIGNALING AND ANERGY | Bléry et al.
Fmax is the maximal fl   uorescence obtained for samples incubated for 
10 min at 4°C, left untreated for 1 h, and not put back at 37°C (no MESNA, 
0 min, 4°C).
Filipin staining. This protocol is adapted from Muller et al. (21). Splenocytes 
were fi  xed in 3.2% PFA in PBS and stained for B220. Cells were then resus-
pended in PBS containing 30 μg/ml fi  lipin, held at room temperature for 2 h, 
and directly analyzed on an LSR fl  ow cytometer (Becton Dickinson).
Online supplemental material. Figs. S1  –S6 show a series and additional 
images of cells from confocal fl  uorescence microscopy, and a schematic ex-
plaining the methods used for fl  ow cytometric measurement of endocytosis 
and recycling. Figs. S1–S6 are available at http://www.jem.org/cgi/content/
full/jem.20060552/DC1.
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